BR9610133A - Vetor recombinante, organismo hospedeiro gram-positivo, processos para engenheirar um organismo hospedeiro gram-positivo, para mostrar a proteìna ou polipeptìdeo desejado em sua superfìcie, para imobilizar organismo hospedeiro gram-positivo e para triar uma coleção de substâncias, vacina, composição e usos de organismos hospedeiro e da composição. - Google Patents
Vetor recombinante, organismo hospedeiro gram-positivo, processos para engenheirar um organismo hospedeiro gram-positivo, para mostrar a proteìna ou polipeptìdeo desejado em sua superfìcie, para imobilizar organismo hospedeiro gram-positivo e para triar uma coleção de substâncias, vacina, composição e usos de organismos hospedeiro e da composição.Info
- Publication number
- BR9610133A BR9610133A BR9610133-4A BR9610133A BR9610133A BR 9610133 A BR9610133 A BR 9610133A BR 9610133 A BR9610133 A BR 9610133A BR 9610133 A BR9610133 A BR 9610133A
- Authority
- BR
- Brazil
- Prior art keywords
- gram
- host organism
- composition
- positive
- positive host
- Prior art date
Links
- 239000013598 vector Substances 0.000 title abstract 4
- 229920001184 polypeptide Polymers 0.000 title abstract 3
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 3
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 3
- 102000004169 proteins and genes Human genes 0.000 title abstract 3
- 108090000623 proteins and genes Proteins 0.000 title abstract 3
- 239000000126 substance Substances 0.000 title 1
- -1 vaccine Substances 0.000 title 1
- 229960005486 vaccine Drugs 0.000 title 1
- 230000008520 organization Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
- C12N15/625—DNA sequences coding for fusion proteins containing a sequence coding for a signal sequence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/08—Clostridium, e.g. Clostridium tetani
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
- C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Clostridium (G)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/36—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Actinomyces; from Streptomyces (G)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
- C12N11/16—Enzymes or microbial cells immobilised on or in a biological cell
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
- C12N15/746—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for lactic acid bacteria (Streptococcus; Lactococcus; Lactobacillus; Pediococcus; Enterococcus; Leuconostoc; Propionibacterium; Bifidobacterium; Sporolactobacillus)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/035—Fusion polypeptide containing a localisation/targetting motif containing a signal for targeting to the external surface of a cell, e.g. to the outer membrane of Gram negative bacteria, GPI- anchored eukaryote proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
- C07K2319/22—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a Strep-tag
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/55—Fusion polypeptide containing a fusion with a toxin, e.g. diphteria toxin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Veterinary Medicine (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Mirrors, Picture Frames, Photograph Stands, And Related Fastening Devices (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Adhesive Tapes (AREA)
- Details Of Rigid Or Semi-Rigid Containers (AREA)
- Vehicle Interior And Exterior Ornaments, Soundproofing, And Insulation (AREA)
- Sheet Holders (AREA)
Abstract
"VETOR RECOMBINANTE, ORGANISMO HOSPEDEIRO GRAM-POSITIVO, PROCESSOS PARA ENGENHEIRAR UM ORGANISMO HOSPEDEIRO GRAM-POSITIVO, PARA MOSTRAR A PROTEìNA OU POLIPEPTìDEO DESEJADO EM SUA SUPERFìCIE, PARA IMOBILIZAR ORGANISMO HOSPEDEIRO GRAM-POSITIVO E PARA TRIAR UMA COLEçãO DE SUBSTâNCIAS, VACINA, COMPOSIçãO E USOS DE ORGANISMO HOSPEDEIRO E DA COMPOSIçãO". Processos para obter expressão de superfície de uma proteína ou polipeptídeo desejado em organismos hospedeiros Gram-positivos são providos. Além disso, os vetores utilizáveis nestes processos assim como os organismos hospedeiros Gram-positivos transformados com estes vetores são descritos.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9518323.2A GB9518323D0 (en) | 1995-09-07 | 1995-09-07 | Materials and methods relating to the attachment and display of substances on cell surfaces |
PCT/GB1996/002195 WO1997009437A1 (en) | 1995-09-07 | 1996-09-06 | Materials and methods relating to the attachment and display of substances on cell surfaces |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9610133A true BR9610133A (pt) | 1999-12-21 |
Family
ID=10780370
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9610133-4A BR9610133A (pt) | 1995-09-07 | 1996-09-06 | Vetor recombinante, organismo hospedeiro gram-positivo, processos para engenheirar um organismo hospedeiro gram-positivo, para mostrar a proteìna ou polipeptìdeo desejado em sua superfìcie, para imobilizar organismo hospedeiro gram-positivo e para triar uma coleção de substâncias, vacina, composição e usos de organismos hospedeiro e da composição. |
Country Status (17)
Country | Link |
---|---|
US (1) | US6190662B1 (pt) |
EP (1) | EP0848756B1 (pt) |
JP (1) | JP4180111B2 (pt) |
KR (1) | KR19990044528A (pt) |
CN (1) | CN1201493A (pt) |
AT (1) | ATE270337T1 (pt) |
AU (1) | AU729449B2 (pt) |
BR (1) | BR9610133A (pt) |
CA (1) | CA2231372A1 (pt) |
DE (1) | DE69632827T2 (pt) |
GB (1) | GB9518323D0 (pt) |
HK (1) | HK1014337A1 (pt) |
MX (1) | MX9801864A (pt) |
NO (1) | NO980976L (pt) |
NZ (1) | NZ316580A (pt) |
WO (1) | WO1997009437A1 (pt) |
ZA (1) | ZA967562B (pt) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5821088A (en) * | 1990-05-11 | 1998-10-13 | Siga Pharmaceuticals, Inc. | Use of gram-positive bacteria to express recombinant proteins |
GB9521568D0 (en) * | 1995-10-20 | 1995-12-20 | Lynxvale Ltd | Delivery of biologically active polypeptides |
DE19735105A1 (de) * | 1997-08-13 | 1999-03-04 | Univ Albert Ludwigs Freiburg | Transportsystem zur Einbringung von Proteinen in Zielzellen mit Hilfe eines Fusionsproteins, Nucleinsäurekonstrukte kodierend für die Komponenten des Transportsystems und Arzneimittel, die Komponenten des Transportsystems umfassen |
EP0916726A1 (en) * | 1997-11-13 | 1999-05-19 | Rijksuniversiteit te Groningen | Attaching substances to micro-organisms |
US6100388A (en) * | 1998-03-16 | 2000-08-08 | Biogaia Biologies Ab | Lactobacilli harboring aggregation gene as a vaccine delivery vehicle |
EP1012245A1 (en) * | 1998-06-25 | 2000-06-28 | Korea Green Cross Corporation | Surface expression system of hepatitis b virus surface antigen and core antigen of hepatitis c virus by using ice-nucleation protein |
KR100313135B1 (ko) | 1999-02-22 | 2001-11-05 | 윤덕용 | 세포 표면 발현 모체로서의 대장균 유래 세포외막 단백질 c(o |
PT1739178E (pt) * | 1999-07-05 | 2010-11-17 | Actogenix Nv | Libertação de péptidos trifólios |
IL154284A0 (en) * | 2000-09-25 | 2003-09-17 | Nestle Sa | Lactic acid bacteria capable of reducing an individual's tendency to develop allergic reactions |
AU1120102A (en) * | 2000-11-02 | 2002-05-15 | Univ Singapore | AopB gene, protein, homologs, fragments and variants thereof, and their use for cell surface display |
EP1239032A1 (en) | 2001-03-02 | 2002-09-11 | Société des Produits Nestlé S.A. | Lactic acid bacteria as agents for treating and preventing allergy |
US7780961B2 (en) * | 2001-05-03 | 2010-08-24 | Actogenix N.V. | Self-containing Lactococcus strain |
JP2005529622A (ja) * | 2002-06-19 | 2005-10-06 | ヴェーイーベー・ヴェーゼットウェー | 腸吸収を促進するための方法および手段 |
US7527966B2 (en) * | 2002-06-26 | 2009-05-05 | Transgenrx, Inc. | Gene regulation in transgenic animals using a transposon-based vector |
JP2006520584A (ja) | 2002-11-08 | 2006-09-14 | アブリンクス エン.ヴェー. | 安定化単一ドメイン抗体 |
BRPI0316092B8 (pt) | 2002-11-08 | 2021-05-25 | Ablynx Nv | anticorpos de domínio único direcionados contra o fator de necrose tumoral alfa e usos para os mesmos |
WO2004046346A2 (en) * | 2002-11-15 | 2004-06-03 | Vib Vzw | Self-containing lactobacillus strain |
CN101076599A (zh) * | 2003-01-29 | 2007-11-21 | 奥赛尔股份有限公司 | 细菌中生物学活性蛋白质的表面表达 |
CA2539452C (en) * | 2003-09-17 | 2013-10-29 | Guava Technologies, Inc. | Compositions and methods for analysis of target analytes |
US7456011B2 (en) * | 2005-01-12 | 2008-11-25 | Osel, Inc. | Modified cyanovirin-n polypeptide |
EP2119450B1 (en) | 2005-11-29 | 2013-02-13 | Actogenix N.V. | Induction of mucosal tolerance to pancreatic islet beta-cell autoantigens |
BRPI0807857A2 (pt) | 2007-01-25 | 2014-05-27 | Actogenix Nv | Tratamento de doença imune por meio de distribuição através da mucosa de antígenos. |
EP1972350A1 (en) * | 2007-03-20 | 2008-09-24 | Rijksuniversiteit Groningen | Dual targeting system |
WO2009137763A2 (en) * | 2008-05-08 | 2009-11-12 | Emory University | Methods and compositions for the display of polypeptides on the pili of gram-positive bacteria |
JP2012504116A (ja) * | 2008-09-29 | 2012-02-16 | アクトジェニックス・エヌブイ | 粘膜での微生物のコロニー形成の低減 |
WO2014039746A1 (en) | 2012-09-07 | 2014-03-13 | Emory University | Hiv immune stimulating compositions comprising recombinantly expressed pili on bacteria and methods related thereto |
EP2897638A1 (en) | 2012-09-24 | 2015-07-29 | Montana State University-Bozeman | Recombinant lactococcus lactis expressing escherichia coli colonization factor antigen i (cfa/i) fimbriae and their methods of use |
JP2024500837A (ja) * | 2020-12-23 | 2024-01-10 | チャン ザッカーバーグ バイオハブ, インコーポレイテッド | 抗原特異的t細胞を惹起するように操作された細菌 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5616686A (en) | 1990-05-11 | 1997-04-01 | The Rockefeller University | Polypeptide of a hybrid surface protein by bacteria |
US5348867A (en) * | 1991-11-15 | 1994-09-20 | George Georgiou | Expression of proteins on bacterial surface |
AU674311B2 (en) * | 1992-03-13 | 1996-12-19 | Rockefeller University, The | Delivery and expression of a hybrid surface protein on the surface of gram positive bacteria |
-
1995
- 1995-09-07 GB GBGB9518323.2A patent/GB9518323D0/en active Pending
-
1996
- 1996-09-06 ZA ZA9607562A patent/ZA967562B/xx unknown
- 1996-09-06 NZ NZ316580A patent/NZ316580A/en not_active IP Right Cessation
- 1996-09-06 AT AT96929431T patent/ATE270337T1/de not_active IP Right Cessation
- 1996-09-06 JP JP51098397A patent/JP4180111B2/ja not_active Expired - Fee Related
- 1996-09-06 CA CA002231372A patent/CA2231372A1/en not_active Abandoned
- 1996-09-06 BR BR9610133-4A patent/BR9610133A/pt not_active Application Discontinuation
- 1996-09-06 WO PCT/GB1996/002195 patent/WO1997009437A1/en active IP Right Grant
- 1996-09-06 KR KR1019980701776A patent/KR19990044528A/ko not_active Application Discontinuation
- 1996-09-06 DE DE69632827T patent/DE69632827T2/de not_active Expired - Lifetime
- 1996-09-06 AU AU68844/96A patent/AU729449B2/en not_active Ceased
- 1996-09-06 EP EP96929431A patent/EP0848756B1/en not_active Expired - Lifetime
- 1996-09-06 CN CN96198087A patent/CN1201493A/zh active Pending
-
1998
- 1998-03-06 NO NO980976A patent/NO980976L/no unknown
- 1998-03-06 US US09/036,609 patent/US6190662B1/en not_active Expired - Lifetime
- 1998-03-09 MX MX9801864A patent/MX9801864A/es unknown
- 1998-12-24 HK HK98115718A patent/HK1014337A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
GB9518323D0 (en) | 1995-11-08 |
HK1014337A1 (en) | 1999-09-24 |
JPH11511983A (ja) | 1999-10-19 |
US6190662B1 (en) | 2001-02-20 |
NO980976D0 (no) | 1998-03-06 |
DE69632827T2 (de) | 2005-07-07 |
CA2231372A1 (en) | 1997-03-13 |
NO980976L (no) | 1998-05-06 |
KR19990044528A (ko) | 1999-06-25 |
CN1201493A (zh) | 1998-12-09 |
DE69632827D1 (de) | 2004-08-05 |
AU729449B2 (en) | 2001-02-01 |
ATE270337T1 (de) | 2004-07-15 |
JP4180111B2 (ja) | 2008-11-12 |
WO1997009437A1 (en) | 1997-03-13 |
EP0848756A1 (en) | 1998-06-24 |
AU6884496A (en) | 1997-03-27 |
ZA967562B (en) | 1998-03-06 |
EP0848756B1 (en) | 2004-06-30 |
MX9801864A (es) | 1998-11-29 |
NZ316580A (en) | 1999-09-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9610133A (pt) | Vetor recombinante, organismo hospedeiro gram-positivo, processos para engenheirar um organismo hospedeiro gram-positivo, para mostrar a proteìna ou polipeptìdeo desejado em sua superfìcie, para imobilizar organismo hospedeiro gram-positivo e para triar uma coleção de substâncias, vacina, composição e usos de organismos hospedeiro e da composição. | |
IL96907A0 (en) | Proteins produced by human lymphocytes,a dna sequence coding for said proteins and their pharmaceutical and biological application | |
ATE189478T1 (de) | Für die reinigung bestimmte klonierung von peptiden | |
DE69522216T2 (de) | Zielzellen-bindende chimäre Peptide | |
DE69433240D1 (de) | Apoptosegen von wirbeltieren, zusammensetzungen und verwendungen | |
ATE353906T1 (de) | Cd27 ligand | |
ES2056817T5 (es) | Transformacion de trichoderma. | |
ATE184052T1 (de) | Gdf-1 und uog1 proteine | |
DE3650751D1 (de) | Antikörper gegen Saugetier-Interleukin-4 und Peptide verwendbar als Antigenen für deren Herstellung | |
BR9809445A (pt) | Polipeptìdeo compreendendo uma porção imunogênica de um antìgeno de m. tubercolosis, molécula de dna, vetor de expressão, célula hospedeira, composição farmacêutica, vacina, proteìna de fusão, processos para indução de imunidade protetora em um paciente, processo de detecção de tuberculose em um paciente,e , kit de diagnóstico. | |
KR900013979A (ko) | 사람 유두종비루스형 16의 e7 단백질상의 면역원성 영역 | |
AU1860395A (en) | Novel human beta 2 integrin alpha subunit | |
BR9810907A (pt) | Anticorpos monoclonais e policlonais, peptìdeo suscetìvel de gerar um anticorpo, agente imunogênico, sequência de nucleotìdeos, composição farmacêutica, uso de pelo menos um anticorpo, kit de diagnóstico, e, processo para preparar um agente imunogênico | |
DK164940C (da) | Polypeptid med human-gamma-interferonaktivitet, genteknologisk fremgangsmaade til fremstilling deraf, hybrid-plasmider indeholdende en dna-sekvens, der koder for peptidet, vaertsorganismer indeholdende hybridplasmiderne, samt laegemidler, som indeholder polypeptidet | |
BR9509172A (pt) | Proteina de via de complemento nativa sequéncia de dna construção de dna conjugado uso de uma proteína processo para reduzir proteina de via de complemento em um mamifero e formulação farmacéutica | |
DE3382520D1 (de) | Dns die eine sequenz enthalten die fuer ein kristallprotein oder ein polypeptid mit insektiziden eigenschaften kodiert, mit solcher dns transformierte mikroorganismen und zusammensetzungen die diese kristallproteine, polypeptide oder mikroorganismen enthalt. | |
MX9203138A (es) | Dominio de enlace cd2-de antigeno 3 (lfa-3) asociado con funcion linfositos. | |
DE3881023D1 (de) | Proteine, expressionsvektoren, die fuer solche proteine kodierende dna enthalten und zellen, die solche expressionsvektoren enthalten. | |
ATE164311T1 (de) | Orale, pharmazeutische zusammensetzungen das ein protein oder peptide, eine antikoerper und polymerkugeln enthalten | |
AU590861B2 (en) | New human lymphotoxin (TNF-beta) polypeptides their prepartion and use | |
ITRM920506A1 (it) | Regioni antigeniche dei complessi tpl e anticorpi diretti contro di essi. | |
BR0014634A (pt) | Proteìnas dp de trigo e uso das mesmas | |
PT676413E (pt) | Proteina de ligacao a interferoes alfa/beta, sua preparacao e utilizacao | |
BR9712968A (pt) | Genes codificando proteìnas micobacterianas associadas com ligante de células e registro de células e uso destes | |
AU1948788A (en) | Expression of immunologically active proteins of human b-lymphotropic virus |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EG | Technical examination (opinion): publication of technical examination (opinion) | ||
FC | Decision: refusal |